A case of sedation secondary to a trial of lisdexamfetamine

Muhammad Hassan Majeed; Saad Wasiq; Ahmad Mumtaz; Sadiq Naveed; Ali Ahsan Ali

doi:10.4088/PCC.18l02396

A case of sedation secondary to a trial of lisdexamfetamine

Muhammad Hassan Majeed
, Saad Wasiq
, Ahmad Mumtaz
, Sadiq Naveed
, Ali Ahsan Ali

Psychiatry

Stony Brook University

Natchaug Hospital
University of Kansas
Elmhurst Hospital Center

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The American Academy of Child and Adolescent Psychiatry1 has endorsed stimulants and behavioral therapy as the mainstay treatment for attention-deficit/hyperactivity disorder (ADHD). Lisdexamfetamine dimesylate is a prodrug usually prescribed for the treatment of ADHD and binge-eating disorder. Common side effects include anorexia, decreased appetite, irritability, nausea, and insomnia.2 We present the case of a 6-year-old boy diagnosed with ADHD who, when administered a trial of lisdexamfetamine, developed excessive daytime sleepiness (EDS).

Original language	English
Article number	18l02396
Journal	Primary Care Companion to the Journal of Clinical Psychiatry
Volume	21
Issue number	3
DOIs	https://doi.org/10.4088/PCC.18l02396
State	Published - 2019

Access to Document

10.4088/PCC.18l02396

Cite this

@article{4df4442703494cfa8b7c05cf05664ad6,

title = "A case of sedation secondary to a trial of lisdexamfetamine",

abstract = "The American Academy of Child and Adolescent Psychiatry1 has endorsed stimulants and behavioral therapy as the mainstay treatment for attention-deficit/hyperactivity disorder (ADHD). Lisdexamfetamine dimesylate is a prodrug usually prescribed for the treatment of ADHD and binge-eating disorder. Common side effects include anorexia, decreased appetite, irritability, nausea, and insomnia.2 We present the case of a 6-year-old boy diagnosed with ADHD who, when administered a trial of lisdexamfetamine, developed excessive daytime sleepiness (EDS).",

author = "Majeed, \{Muhammad Hassan\} and Saad Wasiq and Ahmad Mumtaz and Sadiq Naveed and Ali, \{Ali Ahsan\}",

note = "Publisher Copyright: {\textcopyright} 2019 Physicians Postgraduate Press, Inc.",

year = "2019",

doi = "10.4088/PCC.18l02396",

language = "English",

volume = "21",

journal = "Primary Care Companion to the Journal of Clinical Psychiatry",

issn = "1523-5998",

publisher = "Physicians Postgraduate Press Inc.",

number = "3",

}

TY - JOUR

T1 - A case of sedation secondary to a trial of lisdexamfetamine

AU - Majeed, Muhammad Hassan

AU - Wasiq, Saad

AU - Mumtaz, Ahmad

AU - Naveed, Sadiq

AU - Ali, Ali Ahsan

PY - 2019

Y1 - 2019

N2 - The American Academy of Child and Adolescent Psychiatry1 has endorsed stimulants and behavioral therapy as the mainstay treatment for attention-deficit/hyperactivity disorder (ADHD). Lisdexamfetamine dimesylate is a prodrug usually prescribed for the treatment of ADHD and binge-eating disorder. Common side effects include anorexia, decreased appetite, irritability, nausea, and insomnia.2 We present the case of a 6-year-old boy diagnosed with ADHD who, when administered a trial of lisdexamfetamine, developed excessive daytime sleepiness (EDS).

AB - The American Academy of Child and Adolescent Psychiatry1 has endorsed stimulants and behavioral therapy as the mainstay treatment for attention-deficit/hyperactivity disorder (ADHD). Lisdexamfetamine dimesylate is a prodrug usually prescribed for the treatment of ADHD and binge-eating disorder. Common side effects include anorexia, decreased appetite, irritability, nausea, and insomnia.2 We present the case of a 6-year-old boy diagnosed with ADHD who, when administered a trial of lisdexamfetamine, developed excessive daytime sleepiness (EDS).

UR - https://www.scopus.com/pages/publications/85066870726

U2 - 10.4088/PCC.18l02396

DO - 10.4088/PCC.18l02396

M3 - Article

C2 - 31125193

SN - 1523-5998

VL - 21

JO - Primary Care Companion to the Journal of Clinical Psychiatry

JF - Primary Care Companion to the Journal of Clinical Psychiatry

IS - 3

M1 - 18l02396

ER -

A case of sedation secondary to a trial of lisdexamfetamine

Abstract

Access to Document

Other files and links

Fingerprint

Cite this